GSK Investigational Site

Allen, Texas 75013

0 studies enrolling now · 4 studies all time

What they study most

Asthma, Systemic Lupus Erythematosus

Studies at this site

• Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry — Completed
• An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103) — Completed
• A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype — Completed
• 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old — Completed